Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children

Transplantation Proceedings

Volumn 28, Issue 5, 1996, Pages 2759-2760

  Green, M ^a   Reyes, J ^a   Jabbour, N ^a   Yunis, E ^a   Putnam, P ^a   Todo, S ^a   Rowe, D ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

CLINICAL ARTICLE; CONFERENCE PAPER; EPSTEIN BARR VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS; VIRUS INFECTION;

ANTIVIRAL AGENTS; CHILD; DNA, VIRAL; GANCICLOVIR; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HLA-DQ ANTIGENS; HUMANS; INTESTINES; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029797303     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)